Cresanto Global Board Meeting Scheduled to Review Q1 Results and Corporate Office Changes
Cresanto Global Ltd, formerly known as Raymed Labs Limited, has announced a Board of Directors meeting set for Thursday, August 13, 2026. The company is scheduled to review and approve several critical matters during this meeting.The agenda items intended for consideration and approval by the Board include the Un-audited Financial Results of the Company for the first quarter ended June 30, 2026. Additionally, the Board will consider the Limited Review Report for the same quarter. A key operational decision on the table is also the change in the corporate office of the Company and the designated place for maintaining and keeping the accounts books.
In adherence to its internal Prohibition of Insider Trading Code, the company confirmed that the Window Closure period for Designated Persons remains closed. This closure was initiated from Wednesday, July 1, 2026, and will remain active until a period equivalent to 48 hours after the declaration of Unaudited Financial Results on Thursday, August 13, 2026.
The Board is also scheduled to consider any other business with the permission of the chair.
Stock Price Movement
Shares of Cresanto Global Ltd settled at ₹4.88 on Monday, registering zero percent movement as trading concluded for the day. The stock remained completely locked at this price point throughout the session, with its intraday high and low remaining identical.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.